It was reported that the implantable cardioverter defibrillator (icd) recorded intermittent oversensing noise in the right atrial (ra) channel.Boston scientific technical services reviewed the available data and confirmed the noise/artefact and recommend further review in-clinic where one can assess lead integrity while performing proactive maneuvers.No adverse patient effects were reported.The device and competitor ra lead remain in-service.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|